World Evidence 2027

Evaluate AI-driven health economics modeling, optimize global real-world data (RWD) generation pipelines, and navigate joint Health Technology Assessment (HTA) frameworks at the World Evidence, Pricing & Access Congress 2027 (World EPA Congress). Organized by Terrapinn, Europe’s premier congress dedicated to pharmaceutical market access, pricing, and evidence generation returns to the RAI Amsterdam Conference Centre for 2 high-impact business days. Connecting over 1,500 senior pharma market access vice presidents, HEOR leads, healthcare payers, regulatory authority officials, and patient advocacy representatives from 50+ countries, the event features 10 dedicated content streams covering rare disease access, cell & gene therapy reimbursement, synthetic control arms, and value-based healthcare contracts. Attendees gain direct access to expert keynote panels, interactive roundtable workshops, innovative health-tech pitch showcases, and strategic B2B networking shaping global access to novel medicines.